Corundum Convergence Institute and the University of Tokyo's International Research Center for Neurointelligence Launch Inaugural Neuroscience Entrepreneurship Workshop
TOKYO, June 25, 2025 /PRNewswire/ -- Corundum Convergence Institute (CCI), a non-profit venture fueling groundbreaking research at the intersection of neuroscience and systems biology, today announced it has partnered with the International Research Center for Neurointelligence (IRCN) at the University of Tokyo to launch the inaugural Neuro-inspired Computation and Entrepreneurship Workshop.
The workshop runs June 30–July 1 and on July 7, 2025 at the University of Tokyo. It will complement the IRCN and Chen Institute's Joint Course on Neuro-inspired Computation, which will take place July 2–5.
Bridging the worlds of neuroscience innovation, artificial intelligence and entrepreneurship, the workshop will introduce participants to foundational startup concepts, emphasizing early-stage venture creation, global market insights and investment strategies. The program is tailored to equip scientists and aspiring entrepreneurs with the tools and mindset to translate bold research into real-world impact.
"The Neuro-inspired Computation and Entrepreneurship Workshop presents an exciting opportunity to create an ecosystem with the potential to become a global engine for startup creation," said Shunsuke Nagao, President of Corundum Convergence Institute and CFO of Corundum Systems Biology. "CCI is committed to nurturing the next generation of entrepreneurs, guiding the process of commercializing cutting-edge research. We are delighted to partner with IRCN for this initiative which perfectly aligns with our vision and goals."
Throughout the program, participants will have the opportunity to engage with leading experts presenting on topics including product-market fit, intellectual property, financing and R&D strategies. Distinguished speakers include neurotech entrepreneur, Alain Prochiantz, PhD, who will deliver a keynote session, and neurotech strategist Jojo Platt, who will introduce attendees to the spirit of entrepreneurial leadership and innovation.
"This program embodies our shared vision of what neuroscience innovation can become when disciplines, generations and cultures converge," said Prof. Takao Hensch, Director of the International Research Center for Neurointelligence, Professor of Molecular and Cellular Biology at the Harvard Center for Brain Science, and Professor of Neurology at Harvard Medical School. "By infusing science and entrepreneurship with the spirit of collaboration, we hope to inspire a new generation of leaders who will transform their curiosity into real-world impact. Together with Corundum, we are cultivating a community where the next big ideas in neurotech innovation can flourish."
A highlight of the workshop will be an immersive session led by a team from Harvard University's Lemann Program on Creativity and Entrepreneurship (LPCE), focused on venture storytelling and pitch readiness. The session will emphasize both cross-disciplinary and cross-generational collaboration, particularly the integration of the liberal arts with sciences and entrepreneurship, which aligns with the vision of CCI and IRCN. LPCE is also actively engaged in building international communities outside of its Boston base, making Japan a future site for this growing global network of researchers, innovators and entrepreneurs.
About Corundum Convergence Institute
Corundum Convergence Institute (CCI) is a non-profit organization committed to advancing transformative research at the frontiers of neuroscience, systems biology, and artificial intelligence. By focusing on early-stage innovation in complex, high-impact fields, CCI supports the development of products and technologies leading to paradigm shifts in healthcare, including novel therapeutic approaches to neuro-inspired AI and improved diagnostics for neurodegenerative and metabolic conditions. CCI's multidisciplinary approach fosters convergence across fields, enabling scientists and entrepreneurs to explore the intersections of science, human biology and advanced technology in ways that will fundamentally reshape health and wellbeing. CCI is an independently governed entity created by fellow Corundum Corp venture builders and funds Corundum Neuroscience and Corundum Systems Biology. As part of the greater Corundum network, CCI offers a creative path to translate bold scientific ideas to real-world impact.
For company updates and information, follow Corundum Convergence Institute on LinkedIn or visit https://cci-fund.org/.
Media Contact:
Danny SudwartsFINN Partners for Corundumdanny.sudwarts@finnpartners.com
View original content:https://www.prnewswire.com/news-releases/corundum-convergence-institute-and-the-university-of-tokyos-international-research-center-for-neurointelligence-launch-inaugural-neuroscience-entrepreneurship-workshop-302490771.html
SOURCE Corundum Convergence Institute
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
32 minutes ago
- Bloomberg
Israel Urges China to Put Economic Pressure on Iran
Israel's Consul General in Shanghai, Ravit Baer, says China should use its economic and political influence to rein in Iran's military and nuclear ambitions. Speaking to The China Show, Baer said China is the only one capable of influencing Iran. Bloomberg has reached out to the Iranian consulate in Shanghai for a response. (Source: Bloomberg)
Yahoo
41 minutes ago
- Yahoo
Trump sees India trade deal, skeptical on progress with Japan
STORY: With one week to go before his deadline for trade deals, Donald Trump is feeling hopeful about talks with at least one major country: ''I think we're going to have a deal with India, possibly, and that's going to be a different kind of a deal. It's going to be a deal where we're able to go in and compete. Right now, India doesn't accept anybody in. I think India's going to do that and if they do that, we're going to have a deal for less much less tariffs.' The U.S. President spoke to reporters on Air Force One on Tuesday (July 1). He said he wasn't thinking about extending the July 9 deadline for agreements. And he again expressed doubt about a deal with Japan: 'They and others are so spoiled from having ripped us off for 30, 40 years; that it's really hard for them to make a deal. You know, it's very hard.' Trump said Japan had refused to take American rice, despite having a shortage of the staple grains. And he said Tokyo had been 'unfair' more broadly, citing its big trade surplus in cars as evidence. The president said he could impose a 35% tariff on the country - or well above the 24% he announced in April and then paused. Earlier Tuesday, Japan's chief cabinet secretary said Tokyo would continue talking to Washington, but would not sacrifice its agriculture sector in order to get a deal. India's foreign minister said this week that talks were at an 'intricate' stage. Sticking points are thought to include duties on car parts, steel and farm goods. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Raytech Holding Limited Announces Closing of $5.197 Million Public Offering of its Ordinary Shares
Hong Kong, July 01, 2025 (GLOBE NEWSWIRE) -- Raytech Holding Limited (NASDAQ: RAY) (the 'Company'), a Hong Kong-headquartered company specializing in design, sourcing and wholesale of personal care electrical appliances for international brand owners, today announced the closing of its public offering ('Offering') of 25,985,000 ordinary shares at a public offering price of $0.20 per ordinary share on July 1, 2025. Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $5.197 million. R.F. Lafferty & Co., Inc. acted as sole placement agent in connection with the Offering. Loeb & Loeb LLP acted as counsel to the Company regarding U.S. securities law matters and Zarif Law Group P.C. acted as U.S. securities counsel for the placement agent. The securities described above were offered pursuant to a registration statement on Form F-1, as amended (File No. 333-287842) (the 'Registration Statement'), which was declared effective by the U.S. Securities and Exchange Commission (the 'SEC') on June 30, 2025. The Offering is being made only by means of a prospectus which is a part of the Registration Statement. A preliminary prospectus relating to the Offering has been filed with the SEC. Copies of the final prospectus relating to the Offering, when available, may be obtained from R.F. Lafferty & Co., Inc., 40 Wall Street, 27th Floor, New York, NY 10004, at +1 (212) 293-9090. This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Raytech Holding Limited Raytech Holding Limited is a Hong Kong-headquartered company with over 10 years of experience in the personal care electrical appliance industry. Through its operating subsidiary in Hong Kong, it sources and wholesales a diverse range of personal care electrical appliances ranging from hair styling, tooling, trimmer, eyelash curler, neck care, to nail care and other body and facial care appliances for international brand owners, providing integrated product design, production processing, and manufacturing solutions. For more information please visit: Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as 'may,' 'will,' 'intend,' 'should,' 'believe,' 'expect,' 'anticipate,' 'project,' 'estimate' or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These forward-looking statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the 'Risk Factors' section of the Company's annual report on Form 20-F filed with the SEC on July 30, 2024 and the Interim Report on Form 6-K for the six months ended September 30, 2024, filed with the U.S. Securities and Exchange Commission (the 'SEC') on January 10, 2025. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the U.S. Securities and Exchange Commission. For investor and media inquiries, please contact: Investor RelationsWFS Investor Relations Wang, Managing PartnerEmail: services@ +86 13811768599+1 628 283 9214
